Cytomegalovirus (CMV) Antikörper

Produktnummer ABIN6251965

Der Maus Monoklonal anti-Cytomegalovirus Antikörper wird verwendet zum Nachweis von Cytomegalovirus in Proben von Cytomegalovirus (CMV). Er wurde validiert für WB, ELISA, IF und ICC.

Kurzübersicht für Cytomegalovirus (CMV) Antikörper (ABIN6251965)

Target: Cytomegalovirus (CMV)

Reaktivität: Cytomegalovirus (CMV)

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunocytochemistry (ICC)

Klon: CMV100

Produktdetails

Aufreinigung: Protein G purified CMV antibody

Isotyp: IgG1 kappa

Anwendungsinformationen

Applikationshinweise: ELISA: order BSA-free CMV antibody format for coating

Immunocytochemistry (Acetone or paraformaldehyde fixed) 0.5-1 μg/mL for 30 min

IF: 0.5-1 μg/mL

The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the CMV antibody to be titered up or down for optimal performance.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.2 mg/mL

Buffer: PBS with 0.1 mg/mL BSA and 0.05 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot and Store at -20C. Avoid freez-thaw cycles.

Antigendetails

Target: Cytomegalovirus (CMV)

Andere Bezeichnung: Cytomegalovirus

Substanzklasse: Virus

Hintergrund: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.